3rd Circ. Urged To Revive Fosamax MDL
By Emily Field · May 24, 2023, 6:56 PM EDT
Fosamax patients have told the Third Circuit a lower court's decision to toss multidistrict litigation alleging Merck failed to warn of the osteoporosis drug's atypical femoral fracture risk is "riddled with...
To view the full article, register now.